gemcitabine has been researched along with Gastric Outlet Obstruction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kulke, MH | 1 |
Arnoletti, JP; Ben-Josef, E; Bhargava, P; Casper, ES; Kim, P; Malafa, MP; Nakakura, EK; Shibata, S; Talamonti, M; Tempero, M; Wang, H; Willett, C | 1 |
2 review(s) available for gemcitabine and Gastric Outlet Obstruction
Article | Year |
---|---|
Metastatic pancreatic cancer.
Topics: Antineoplastic Agents; Autonomic Nerve Block; Celiac Plexus; Cholestasis; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Digestive System Diseases; Fluorouracil; Gastric Outlet Obstruction; Gemcitabine; Humans; Neoplasm Metastasis; Neuralgia; Palliative Care; Pancreatic Neoplasms; Risk Factors; Stents | 2002 |
Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology.
Topics: Adenocarcinoma; Algorithms; Antigens, Tumor-Associated, Carbohydrate; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Cholestasis; Deoxycytidine; Disease Management; Drainage; Gastric Outlet Obstruction; Gemcitabine; Humans; Lymph Node Excision; Neoplasm Staging; Palliative Care; Pancreatectomy; Pancreatic Neoplasms; Portal Vein; Radiotherapy, Adjuvant; Treatment Outcome | 2007 |